Ownership history in Calydon Capital · 14 quarters on record
This page tracks every 13F SEC filing in which Calydon Capital reported a position in CVS HEALTH CORP COM (CVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 95,781 | -635 | -0.7% | 1.28% | $7.6M | $78.71 |
| 2025 Q3 | ADDED | 96,416 | +44,557 | +85.9% | 1.16% | $7.3M | $74.17 |
| 2025 Q2 | ADDED | 51,859 | +49,181 | +1836.5% | 0.35% | $3.6M | $67.13 |
| 2022 Q4 | ADDED | 2,678 | +146 | +5.8% | 0.06% | $250K | $82.42 |
| 2022 Q3 | ADDED | 2,532 | +190 | +8.1% | 0.06% | $241K | $83.84 |
| 2022 Q2 | ADDED | 2,342 | +55 | +2.4% | 0.06% | $217K | $80.99 |
| 2022 Q1 | ADDED | 2,287 | +175 | +8.3% | 0.05% | $231K | $88.00 |
| 2021 Q4 | REDUCED | 2,112 | -7,688 | -78.4% | 0.05% | $218K | $89.22 |
| 2021 Q1 | ADDED | 9,800 | +5,872 | +149.5% | 0.10% | $737K | $63.88 |
| 2020 Q4 | ADDED | 3,928 | +250 | +6.8% | 0.08% | $268K | $57.61 |
As of 2025 Q4 — sorted by position size